Expertise
Patents (including Industrial Designs)
Patents can be among a company's most valuable assets. Therefore, securing and managing a patent portfolio can be critical to an organization's continuing growth and success.
With one of Canada's largest and most respected patent teams filing more than 3,100 applications each year, we are leaders in patent procurement and protection, and are proven experts in helping clients leverage patent assets.
Team
Our team includes patent lawyers, patent agents, and technical consultants with engineering and scientific disciplines, including several at the Ph. D. level. Fields of expertise include: aerospace, biomedical, chemical, civil, computer science, electrical, industrial, mechanical, metallurgy and material science, biochemistry, biomechanics, biotechnology, chemistry, endocrinology, food science, genetics, immunology, life sciences, microbiology, molecular/cellular biology, neuropsychology, neurophysiology, organic chemistry, pharmacology, physics, physiology, and toxicology.
Our high degree of technical skills combined with acute business acumen enables swift and thorough understanding of technical complexities. Our expertise together with experience helps clients achieve optimal patent asset value from negotiation of technology transfer and licensing agreements through to enforcement of intellectual property rights.
Services
- Patentability, validity, freedom-to-operate (FTO) and infringement opinions
- Patent application preparation, filing and prosecution in Canada
- Patent filing and prosecution in the US and international jurisdictions
- Filings and registrations under the Integrated Circuit Topography Act and the Plant Breeders' Rights Act
- Prior art searches
- Patent portfolio audits and management
- Patent licensing agreements
- Due diligence in commercial transactions
- Notices of Compliance
- Patent litigation and other dispute resolution mechanisms
Events
Patent Law and Practice in Canada
Brian Daley presents at the Chartered Institute of Patent Attorneys' (CIPA) seminar.
More
Institute of Law Clerks of Ontario Annual Conference 2008
Joan van Zant, Kelly Friedman, and Barry Segal present sessions on Navigating Your Way through the Patenting Process, The Sedona Canada Principles, and Demystifying Tax Rollovers.
More
Drug Patents and Legal Forum
Josée S. Gravelle and Jason C. Markwell speak on Canadian access to medicines regime and marketing pharmaceutical products in Canada.
More
Publications
Federal Court Decision on Maintenance Fees and Equity
The Court's decision is noteworthy not only for its analysis of the payment issue but also for its comments on the entitlement to equitable relief from forfeiture.
More
Canada and the United States Launch a Joint Pilot Program for Accelerating Patent Examinations
On January 28, 2008, the Canadian Intellectual Property Office (CIPO) and the United States Patent and Trademark Office (USPTO) will launch a joint pilot program aimed at creating a fast track examination process for patent applications.
More
U.S. Patent and Trademark Office Rule Changes Put on Hold
In August 2007, we reported that the United States Patent and Trademark Office (USPTO) had adopted new rules of practice which, in some instances, would significantly change the way patent applications are prepared, filed, and prosecuted in the U.S.
More
The London Agreement Reduces Translation Requirements for European Patents
It will soon become significantly less costly to obtain patent protection in European countries.
More
Canada's Federal Court of Appeal Makes Important Decision in Patent Invalidity for Obviousness
George Locke, a partner in the IP group, wrote this article in the October 2007 issue of the international IP publication Patent World.
More
Highlights of the U.S. Patent and Trademark Office Rule Changes
The United States Patent and Trademark Office (USPTO) has now adopted new rules of practice which, in some instances, will significantly change the way patent applications are prepared, filed, and prosecuted in the U.S.
More
Enforcement of Patent Rights in Pre-Trial Proceedings
An article co-authored by Brian Daley, a partner at Ogilvy Renault, compares pre-trial procedures in Canada, the United States and the United Kingdom.
More
Patent Invalidity for Obviousness: Canada's Federal Court of Appeal Renders an Important Decision
On June 7, 2007, Canada's Federal Court of Appeal rendered a decision in Novopharm Limited v. Jannsen-Ortho Inc. that dealt with several patent issues.
More
Amendments to Canada's Patent Rules to Come Into Force on June 2, 2007
On June 2, 2007, amendments to Canada's Patent Rules ("Amendments") will come into force.
More
Federal Court of Appeal Ups the Ante for Patentees Litigating under the PM(NOC) Regulations
In Sanofi-Aventis Canada Inc. v. Novopharm Limited 2007 FCA 163 the Federal Court of Appeal has decided that a patentee who unsuccessfully challenges an allegation made by a generic drug manufacturer under the PM(NOC) Regulations cannot re-litigate ...
More
KSR International Co. v. Teleflex Inc.: the United States Supreme Court speaks on patent invalidity for obviousness
On April 30, 2007, the Supreme Court of the United States released its unanimous decision in KSR International Co. v. Teleflex Inc. The Supreme Court reversed a decision of the Court of Appeals for the Federal Circuit ("CAFC") and restored a District ...
More
The Doctrine of Inequitable Conduct May Have Arrived in Canada
In a startling decision released on January 24, 2007, a judge of the Federal Court has deemed a patent to be abandoned based on the patentee's failure to disclose in good faith all appropriate facts in its patent application, and respond in good faith ...
More
In a rush to obtain your U.S. patent?-The USPTO proposes a two-tiered system for examining patent applicationsIn a rush to obtain your U.S. patent?-The USPTO proposes a two-tiered system for examining patent applications
The waiting time to obtain a patent from the American patent office (U.S. Patent and Trademark Office, USPTO) is getting longer and longer, especially in the information technology, telecommunications and business methods sectors. On August 25, 2006 ...
More
If at First You Don't Succeed.
On October 17, 2006, Justice Hughes delivered Reasons for Judgment in Janssen-Ortho Inc. and Daiichi Pharmaceutical Co., Ltd. v. Novopharm Limited,[1] a patent infringement action brought in respect of the drug levofloxacin.
More
Can a Patent Be Invalid as a Result of Misrepresentations Made During Prosecution of the Application?
A recent decision of the Federal Court of Appeal has called into question the long-held principle that a patent cannot be held invalid simply because of misrepresentations made during prosecution of a patent application, at least in the absence of fraud.
More
Bill C-29 - An Act to amend the Patent Act CORRECTION TO SMALL ENTITY
The Canadian Government has amended the Patent Act to allow corrective payments on patents and applications in order to overcome the drastic results of the Canadian Federal Court of Appeal decision in Barton No-Till Disk et al v. Dutch Industries ...
More
Patent Application Requirements
Patent Application Requirements and Useful Information. Contents: Deadlines, Requirements, Examination and Additional Information
More
Overview of Patent Law in Canada
Canada's patent system underwent a major overhaul in 1989. The following important changes were introduced at that time, and are applicable to all patent applications filed since then, as well as to patents issuing therefrom.
More
Canadian Patent Forms / Available Forms
Patent applications may be either wholly in English or in French. Forms do not need to be in the same language as the patent application.
More
Evolution of Canadian Legislation Affecting Innovative Drug Patents
Since the early 1920's, the federal government has struggled with the appropriate level of legislative protection to extend to drug patents.
More
Ontario Proposes to Institute Private Right of Action and Additional Liability for Continuous Disclosure Violations and to Delegate Additional Enforcement Powers to the OSC
On October 30, 2002, the Ontario government introduced Bill 198, an omnibus bill implementing various measures contained in the 2002 Budget and proposing amendments to 29 different statutes.
More
Media Highlights
Ogilvy Renault Congratulates Newly Registered Patent Agents
Ogilvy Renault is pleased to announce that seven of its people have passed their final patent agent exams with flying colours.
More
Ogilvy Renault represents Merck in a successful patent case
In a decision dated October 10, 2006, the Federal Court of Appeal maintained the trial judgment that found Merck`s patent for the medicine lisinopril to be valid and infringed by Apotex Inc.
More
Ogilvy Renault's Robert Mitchell: Recipient of the 2004 International Federation of Intellectual Property Attorneys Award
Ogilvy Renault extends a warm congratulations to Robert Mitchell, patent agent and senior partner in the firm's Intellectual Property group, on receiving the Peter Kirby Memorial Award by the Canadian Group of the International Federation of ...
More
Contacts

Isabelle Chabot
418.640.5174
ichabot@ogilvyrenault.com
Profile

Judith M. Robinson
514.847.4608
jrobinson@ogilvyrenault.com
Profile

Kenneth Sharpe
613.780.8618
ksharpe@ogilvyrenault.com
Profile

Joan Van Zant
416.216.1868
jvanzant@ogilvyrenault.com
Profile

Christian Cawthorn
514.847.4256
ccawthorn@ogilvyrenault.com
Profile










